CoChat

Downregulation of Endothelin Receptor B Contributes to Defective B Cell Lymphopoiesis in Trisomy 21 Pluripotent Stem Cells

MacLean, Glenn A., McEldoon, Jennifer, Huang, Jialiang, Allred, Jeremy, Canver, Matthew C., Orkin, Stuart. H. · 2018 · Scientific Reports
Cited by 22

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Individuals with Trisomy 21 (T21) exhibit numerous hematological abnormalities, including reductions in numbers of circulating B and T lymphocytes. To elucidate molecular mechanisms underlying these phenotypes, we differentiated human isogenic disomic and trisomic pluripotent cells, and observed that trisomic cells showed defects in B cell, but not T cell differentiation. Global gene expression of differentiated, trisomic B cells revealed reduced expression of genes encoding endothelin signaling components, namely the Endothelin Receptor B (EDNRB), and its ligand Endothelin1 (EDN1). Depletion of EDNRB mRNA in cord blood-derived CD34+ cells led to defective B cell differentiation, supporting a hypothesis that low EDNRB expression in T21 contributes to intrinsic lymphoid defects. Further evidence for the role of the EDNRB pathway in B cell differentiation was obtained through CRISPR/Cas9 gene targeting in disomic and trisomic iPS cells. Knockout of EDNRB in both cell backgrounds reduced the capacity for B cell differentiation. Collectively, this work identifies downregulation of EDNRB as a causative factor for impaired B lymphocyte generation in trisomic cells, which may contribute to defects in immune function associated with T21. Furthermore, a novel role for endothelin signaling in regulation of B cell development has been identified.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-018-26123-y

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 33

  1. Parker, S. E. et al. Updated National Birth Prevalence estimates for selected birth defects in the United States, 2004–2006. Birth Defects Res A Clin Mol Teratol 88, 1008–1016 (2010). · DOI · Paper page
  2. Arumugam, A. et al. Down syndrome-A narrative review with a focus on anatomical features. Clin Anat 29, 568–577 (2016). · DOI
  3. Antonarakis, S. E. Parental origin of the extra chromosome in trisomy 21 as indicated by analysis of DNA polymorphisms. Down Syndrome Collaborative Group. N Engl J Med 324, 872–876 (1991). · DOI · Paper page
  4. Roberts, I. & Izraeli, S. Haematopoietic development and leukaemia in Down syndrome. Br J Haematol 167, 587–599 (2014). · DOI · Paper page
  5. Tunstall-Pedoe, O. et al. Abnormalities in the myeloid progenitor compartment in Down syndrome fetal liver precede acquisition of GATA1 mutations. Blood 112, 4507–4511 (2008). · DOI · Paper page
  6. Chou, S. T. et al. Trisomy 21 enhances human fetal erythro-megakaryocytic development. Blood 112, 4503–4506 (2008). · DOI
  7. Martínez, E. et al. Altered immune parameters correlate with infection-related hospitalizations in children with Down syndrome. Hum Immunol 77, 594–599 (2016). · DOI
  8. Schoch, J. et al. Quantitative, Phenotypical, and Functional Characterization of Cellular Immunity in Children and Adolescents With Down Syndrome. J Infect Dis 215, 1619–1628 (2017). · DOI · Paper page
  9. Burgio, G. R. et al. Immunodeficiency in Down’s syndrome: T-lymphocyte subset imbalance in trisomic children. Clin Exp Immunol 33, 298–301 (1978).
  10. Bloemers, B. L. et al. Decreased thymic output accounts for decreased naive T cell numbers in children with Down syndrome. J Immunol 186, 4500–4507 (2011). · DOI
  11. Verstegen, R. H., Kusters, M. A., Gemen, E. F. & DE Vries, E. Down syndrome B-lymphocyte subpopulations, intrinsic defect or decreased T-lymphocyte help. Pediatr Res 67, 563–569 (2010). · DOI
  12. Goldacre, M. J., Wotton, C. J., Seagroatt, V. & Yeates, D. Cancers and immune related diseases associated with Down’s syndrome: a record linkage study. Arch Dis Child 89, 1014–1017 (2004). · DOI · Paper page
  13. Garrison, M. M., Jeffries, H. & Christakis, D. A. Risk of death for children with down syndrome and sepsis. J Pediatr 147, 748–752 (2005). · DOI
  14. Hilton, J. M., Fitzgerald, D. A. & Cooper, D. M. Respiratory morbidity of hospitalized children with Trisomy 21. J Paediatr Child Health 35, 383–386 (1999). · DOI · Paper page
  15. Alford, K. A. et al. Perturbed hematopoiesis in the Tc1 mouse model of Down syndrome. Blood 115, 2928–2937 (2010). · DOI · Paper page
  16. Sontag, S. et al. Modelling IRF8 Deficient human hematopoiesis and dendritic cell development with engineered iPS cells. Stem Cells 35, 898–908 (2017). · DOI
  17. Iizuka, H. et al. Targeted gene correction of RUNX1 in induced pluripotent stem cells derived from familial platelet disorder with propensity to myeloid malignancy restores normal megakaryopoiesis. Exp Hematol 43, 849–857 (2015). · DOI
  18. Maclean, G. A. et al. Altered hematopoiesis in trisomy 21 as revealed through in vitro differentiation of isogenic human pluripotent cells. Proc Natl Acad Sci USA 109, 17567–17572 (2012). · DOI · Paper page
  19. Chou, S. T. et al. Trisomy 21-associated defects in human primitive hematopoiesis revealed through induced pluripotent stem cells. Proc Natl Acad Sci USA 109, 17573–17578 (2012). · DOI
  20. Banno, K. et al. Systematic Cellular Disease Models Reveal Synergistic Interaction of Trisomy 21 and GATA1 Mutations in Hematopoietic Abnormalities. Cell Rep 15, 1228–1241 (2016). · DOI
  21. Kennedy, M. et al. T lymphocyte potential marks the emergence of definitive hematopoietic progenitors in human pluripotent stem cell differentiation cultures. Cell Rep 2, 1722–1735 (2012). · DOI · Paper page
  22. Roy, A. et al. Perturbation of fetal liver hematopoietic stem and progenitor cell development by trisomy 21. Proc Natl Acad Sci USA 109, 17579–17584 (2012). · DOI · Paper page
  23. Lim, J. H. et al. Genome-wide gene expression analysis in the placenta from fetus with trisomy 21. BMC Genomics 18, 720 (2017). · DOI
  24. Rosanò, L., Spinella, F. & Bagnato, A. Endothelin 1 in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer 13, 637–651 (2013). · DOI · Paper page
  25. Frykman, P. K., Cheng, Z., Wang, X. & Dhall, D. Enterocolitis causes profound lymphoid depletion in endothelin receptor B- and endothelin 3-null mouse models of Hirschsprung-associated enterocolitis. Eur J Immunol 45, 807–817 (2015). · doi:10.1002/eji.201444737
  26. Gosain, A. et al. Impaired cellular immunity in the murine neural crest conditional deletion of endothelin receptor-B model of Hirschsprung’s Disease. PLoS One 10, e0128822 (2015). · DOI
  27. Hirose, Y. et al. B-cell precursors differentiated from cord blood CD34+ cells are more immature than those derived from granulocyte colony-stimulating factor-mobilized peripheral blood CD34+ cells. Immunology 104, 410–417 (2001). · DOI
  28. De Leon-Luis, J. et al. Sonographic thymic measurements in Down syndrome fetuses. Prenat Diagn 31, 841–845 (2011). · DOI
  29. Zampieri, B. L. et al. Altered expression of immune-related genes in children with Down syndrome. PLoS One 9, e107218 (2014). · DOI
  30. Bauer, D. E., Canver, M. C. & Orkin, S. H. Generation of genomic deletions in mammalian cell lines via CRISPR/Cas9. J Vis Exp e52118 (2015). · DOI · Paper page
  31. Irizarry, R. A. et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4, 249–264 (2003). · DOI · Paper page
  32. Leek, J. T., Johnson, W. E., Parker, H. S., Jaffe, A. E. & Storey, J. D. The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics 28, 882–883 (2012). · DOI · Paper page
  33. Smyth, G. K. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3, Article3 (2004). · DOI · Paper page

Cited by

See all 22

Metadata

Authors
MacLean, G. A., McEldoon, J., Huang, J., Allred, J., Canver, M. C., & Orkin, S. H.
Venue
Scientific Reports
Published
2018-05-22
Volume
8
Issue
1
ISSN
2045-2322
Cited by
22
References
1
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Downregulation of Endothelin Receptor B Contributes to Defective B Cell Lymphopoiesis in Trisomy 21 Pluripotent Stem Cells. https://app.cochat.ai/papers/10.1038/s41598-018-26123-y
The paper
MacLean, G. A., McEldoon, J., Huang, J., Allred, J., Canver, M. C., & Orkin, S. H. (2018). Downregulation of Endothelin Receptor B Contributes to Defective B Cell Lymphopoiesis in Trisomy 21 Pluripotent Stem Cells. Scientific Reports. https://doi.org/10.1038/s41598-018-26123-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.